FeedBagel

All Topics

Art

STAT+: A year after distressed buyout, what’s become of Bluebird Bio?

Jason Mast

3d ago

Source

STATSTAT+: A year after distressed buyout, what’s become of Bluebird Bio?statnews.com

Snippet from the RSS feed

Bluebird Bio was a dark biotech morality tale when David Meek bought it. He says the new company, Genetix, is already making money.

You might also wanna read

Allbirds Pivots from Footwear to AI Cloud Services, Stock Soars 600%

Allbirds, the shoe company that went public in 2021 but never turned a profit, is undergoing a dramatic transformation. After selling its na

The Verge·2mo ago

Merck KGaA acquires Bio-Techne in $11 billion all-cash deal to bolster life sciences division

Merck KGaA has agreed to acquire Bio-Techne for approximately $11 billion in an all-cash deal, aiming to strengthen its life sciences portfo

cen.acs.org·8d ago

Allbirds rebrands as Smartbird, completes sale of footwear assets in AI pivot

Allbirds, the former sustainable shoe company, has officially rebranded as Smartbird as part of its pivot to an artificial intelligence comp

upi.com·17d ago

Goldman Sachs Report Questions Financial Sustainability of Curative Gene Therapies

Goldman Sachs analysts question whether curing patients is a sustainable business model for biotech companies, particularly those developing

cnbc.com·7mo ago

Biotech venture capital roundup: Osanni Bio leads with $190M Series B

A roundup of recent venture capital financings in the biotech sector, headlined by Osanni Bio's $190 million Series B round to fund drug can

pharmaphorum.com·9d ago

How AI Will Transform Biopharma: The Sequence of Change Matters

Ben Liu, CEO of Formation Bio, argues that AI will transform the pharmaceutical industry unevenly and sequentially. Some parts of drug disco

a16z.news·14d ago

Comments

No comments yet. Be the first.